Literature DB >> 28029608

Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study.

Sepideh Amin-Hanjani1, Tanya N Turan2, Xinjian Du3, Dilip K Pandey4, Linda Rose-Finnell3, DeJuran Richardson5, Mitchell S V Elkind6, Gregory J Zipfel7, David S Liebeskind8, Frank L Silver9, Scott E Kasner10, Philip B Gorelick11, Fady T Charbel3, Colin P Derdeyn12.   

Abstract

BACKGROUND: Despite concerns regarding hypoperfusion in patients with large-artery occlusive disease, strict blood pressure (BP) control has become adopted as a safe strategy for risk reduction of stroke. We examined the relationship between BP control, blood flow, and risk of subsequent stroke in the prospective Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) study.
METHODS: The VERiTAS study enrolled patients with recent vertebrobasilar (VB) transient ischemic attack or stroke and ≥50% atherosclerotic stenosis or occlusion of vertebral or basilar arteries. Hemodynamic status was designated as low or normal based on quantitative magnetic resonance angiography. Patients underwent standard medical management and follow-up for primary outcome event of VB territory stroke. Mean BP during follow-up (<140/90 versus ≥140/90 mm Hg) and flow status were examined relative to subsequent stroke risk using Cox proportional hazards analysis.
RESULTS: The 72 subjects had an average of 3.8 ± 1.2 BP recordings over 20 ± 8 months of follow-up; 39 (54%) had mean BP of<140/90 mm Hg. The BP groups were largely comparable for baseline demographics, risk factors, and stenosis severity. Comparing subgroups stratified by BP and hemodynamic status, we found that patients with both low flow and BP <140/90 mm Hg (n = 10) had the highest risk of subsequent stroke, with hazard ratio of 4.5 (confidence interval 1.3-16.0, P = .02), compared with the other subgroups combined.
CONCLUSIONS: Among a subgroup of patients with VB disease and low flow, strict BP control (BP <140/90) may increase the risk of subsequent stroke.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood flow; blood pressure; magnetic resonance angiography; magnetic resonance imaging; stroke; vertebrobasilar disease

Mesh:

Year:  2016        PMID: 28029608      PMCID: PMC5258769          DOI: 10.1016/j.jstrokecerebrovasdis.2016.09.044

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  16 in total

1.  Hemodynamic Features of Symptomatic Vertebrobasilar Disease.

Authors:  Sepideh Amin-Hanjani; Xinjian Du; Linda Rose-Finnell; Dilip K Pandey; DeJuran Richardson; Keith R Thulborn; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Victor A Aletich; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  Stroke       Date:  2015-05-14       Impact factor: 7.914

2.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.

Authors:  Hisatomi Arima; John Chalmers; Mark Woodward; Craig Anderson; Anthony Rodgers; Stephen Davis; Stephen Macmahon; Bruce Neal
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

3.  Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design.

Authors:  Sepideh Amin-Hanjani; Linda Rose-Finnell; DeJuran Richardson; Sean Ruland; Dilip Pandey; Keith R Thulborn; David S Liebeskind; Gregory J Zipfel; Mitchell S V Elkind; Jeffrey Kramer; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  Int J Stroke       Date:  2010-12       Impact factor: 5.266

4.  Collaterals dramatically alter stroke risk in intracranial atherosclerosis.

Authors:  David S Liebeskind; George A Cotsonis; Jeffrey L Saver; Michael J Lynn; Tanya N Turan; Harry J Cloft; Marc I Chimowitz
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

5.  Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease.

Authors:  P M Rothwell; S C Howard; J D Spence
Journal:  Stroke       Date:  2003-10-30       Impact factor: 7.914

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study.

Authors:  Paul Muntner; Jeff Whittle; Amy I Lynch; Lisandro D Colantonio; Lara M Simpson; Paula T Einhorn; Emily B Levitan; Paul K Whelton; William C Cushman; Gail T Louis; Barry R Davis; Suzanne Oparil
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

8.  New England Medical Center Posterior Circulation registry.

Authors:  Louis R Caplan; Robert J Wityk; Thomas A Glass; Jorge Tapia; Ladislav Pazdera; Hui-Meng Chang; Phillip Teal; John F Dashe; Claudia J Chaves; Joan C Breen; Kostas Vemmos; Pierre Amarenco; Barbara Tettenborn; Megan Leary; Conrad Estol; L Dana Dewitt; Michael S Pessin
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

9.  Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis.

Authors:  Tanya N Turan; George Cotsonis; Michael J Lynn; Seemant Chaturvedi; Marc Chimowitz
Journal:  Circulation       Date:  2007-05-21       Impact factor: 29.690

10.  Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia.

Authors:  William J Powers; William R Clarke; Robert L Grubb; Tom O Videen; Harold P Adams; Colin P Derdeyn
Journal:  Neurology       Date:  2014-02-14       Impact factor: 9.910

View more
  7 in total

1.  Long-term hemodynamic changes and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Tatsuya Higashi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-18       Impact factor: 6.200

2.  Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee.

Authors:  Tanya N Turan; Osama O Zaidat; Gary S Gronseth; Marc I Chimowitz; Antonio Culebras; Anthony J Furlan; Larry B Goldstein; Nestor R Gonzalez; Julius G Latorre; Steven R Messé; Thanh N Nguyen; Rajbeer S Sangha; Michael J Schneck; Aneesh B Singhal; Lawrence R Wechsler; Alejandro A Rabinstein; Mary Dolan O'Brien; Heather Silsbee; Jeffrey J Fletcher
Journal:  Neurology       Date:  2022-03-22       Impact factor: 9.910

3.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

Review 4.  Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.

Authors:  Brian Mac Grory; Shadi Yaghi; Charlotte Cordonnier; Luciano A Sposato; Jose G Romano; Seemant Chaturvedi
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 5.  Blood Pressure Management for Stroke Prevention and in Acute Stroke.

Authors:  Keun-Sik Hong
Journal:  J Stroke       Date:  2017-05-31       Impact factor: 6.967

6.  Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke.

Authors:  Georgios Tsivgoulis; Apostolos Safouris; Dong-Eog Kim; Andrei V Alexandrov
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

7.  Selective neuronal damage and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Kuninori Kusano; Chio Okuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-05-24       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.